Abluminus DES: Sirolimus Drug Eluting Coronary Stent
Abluminus DES+ - Concept Medical - Developing technologies for drug delivery with a strong emphasis on intellectual property.
REVOLUTIONARY DES TO ADDRESS
UNMET CLINICAL NEED

ABLUMINUS DES+ designed by propriety ENVISOLUTION technology in a way that address the unmet clinical needs specially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease.

ABLUMINUS DES+ Receives on-label indication for Diabetes Mellitus and Acute Myocardial infarction.

Sirolimus Eluting

Stent System

Abluminus DES+

Envisolution Technology

  • ABLUMINAL COATING - Abluminus DES+

    ABLUMINAL COATING

    Facilitate mono directional drug release and less systemic exposure of drug leading to faster re-endothelistation

  • FUSION COATING - Abluminus DES+

    FUSION COATING

    Coating on the stent and exposed parts of the balloon facilitate homogenous drug delivery which address diffused proliferative disease and focal restenosis

  • Edge Coating - Abluminus DES+

    Edge Coating

    The additional 0.5mm coating on the edge of the balloon which addresses the edge restenosis

  • Biodegradable Film - Abluminus DES+

    Biodegradable Film

    The formation of circular film with biodegradable polymer facilitate maximum drug delivery in blood wet conditions

TECHNICAL SPECIFICATION

Drug Polymer
Drug Sirolimus
Drug Dose 0.70µg/mm²
Drug Carrier Customized biodegradable polymer matrix
Stent
Stent Material Cobalt Chromium Alloy L605
Strut Thickness 73µm
Strut Width 80µm (hinge) – 120µm (strut)
Average Recoil Less than 5%
Average Foreshortening Less than 1% (Zero foreshortening design)
Delivery System
Delivery System RX stent delivery system
Nominal Pressure 8 bar
Rated Burst Pressure 14 bar
Guide Wire Compatibility (max.) 0.014″
Guiding Catheter Compatibility 5F
Stent Diameter (mm) 2.25, 2.50, 2.75, 3.00, 3.50, 4.00
Stent Length(mm) 8, 12, 16, 20, 24, 28, 32, 36, 40
Crossing Profile 0.038″
Entry Profile 0.016″

ORDERING INFORMATION

Stent
Diameter
Stent Length
08 mm 12 mm 16 mm 20 mm 24 mm 28 mm 32 mm 36 mm 40 mm
2.25mm EAN22508 EAN22512 EAN22516 EAN22520 EAN22524 EAN22528 EAN22532 EAN22536 EAN22540
2.50mm EAN25008 EAN25012 EAN25016 EAN25020 EAN25024 EAN25028 EAN25032 EAN25036 EAN25040
2.75mm EAN27508 EAN27512 EAN27516 EAN27520 EAN27524 EAN27528 EAN27532 EAN27536 EAN27540
3.00mm EAN30008 EAN30012 EAN30016 EAN30020 EAN30024 EAN30028 EAN30032 EAN30036 EAN30040
3.50mm EAN35008 EAN35012 EAN35016 EAN35020 EAN35024 EAN35028 EAN35032 EAN35036 EAN35040
4.00mm EAN40008 EAN40012 EAN40016 EAN40020 EAN40024 EAN40028 EAN40032 EAN40036 EAN40040

Talk to a representative
Fill out a quick form and our representatives will be in touch.


Abluminus DES+

Clinical Programs

Sr. No Study Name Type of Study Target Patients Country Clinical Trials Identifier
Sr. No:  1 Study Name:   ABILITY DIABETES GLOBAL Type of Study:  Prospective, multicenter, multinational, randomized, 2-arm parallel groups Target Patients:  3000 Country:  Global Clinical Trials Identifier:  
Sr. No:  2 Study Name:   Ability RCT Type of Study:  Multi-centre, Single-blinded, Randomized, Investigator-initiated pilot clinical study Target Patients:  165 Patients Country:  Italy Clinical Trials Identifier:  
Sr. No:  3 Study Name:   en-ABL 1 Study Type of Study:  Prospective, Single centre, Non- randomized clinical trial Target Patients:  40 Patients Country:  India Clinical Trials Identifier:  
Sr. No:  4 Study Name:   Dedicate Registry Type of Study:  Prospective, Multi-center, Spontaneous clinical registry Target Patients:  5,000 patients Country:  Global Clinical Trials Identifier:  
Sr. No:  5 Study Name:   en-ABL e-REGISTRY Type of Study:  Multi-center, Prospective, All-comers registry Target Patients:  2,500 patients Country:  India Clinical Trials Identifier:  
“Confidence Through Evidence’”
Get in Touch